US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Retension Pharmaceuticals Inc

11.32

+0.79007.50%

Volume:177.62K

Turnover:2.00M

Market Cap:94.31M

PE:-7.47

High:11.79

Open:10.88

Low:10.16

Close:10.53

52wk High:11.79

52wk Low:9.66

Shares:8.33M

Float Shares:3.30M

Volume Ratio:0.23

T/O Rate:5.38%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.5150

EPS(LYR):-10.6878

ROE:--

ROA:--

PB:-6.32

PE(LYR):-1.06

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Retension Pharmaceuticals Shares Fall After Nasdaq Debut

MT Newswires Live

Retension Pharmaceuticals Debuts on US Stock Market, Shares Drop Over 10% After Opening

Retension Pharmaceuticals Shares Slide in Trading Debut After IPO

City Therapeutics Eyes Valuation of up to $956.3 Million in US IPO Amid Biotech Listing Push

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketl.com/stock/RTSN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"RTSN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RTSN\",,,,,undefined,":{"symbol":"RTSN","market":"US","secType":"STK","nameCN":"Retension Pharmaceuticals Inc","latestPrice":11.32,"timestamp":1791835200000,"preClose":10.53,"halted":0,"volume":177617,"delay":0,"changeRate":0.07502374169040844,"floatShares":3300000,"shares":8331600,"eps":-1.515,"marketStatus":"Pre-Mkt","change":0.79,"latestTime":"10-13 07:22:08 EDT","open":10.88,"high":11.79,"low":10.16,"amount":1996766.939277,"amplitude":0.154796,"askPrice":18.11,"askSize":200,"bidPrice":9.75,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.515,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791898200000},"marketStatusCode":1,"adr":0,"listingDate":1791518400000,"exchange":"NASDAQ","adjPreClose":11.32,"postHourTrading":{"tag":"盘后","latestPrice":11.6175,"preClose":11.32,"latestTime":"19:55 EDT","volume":5451,"amount":63775.2224,"timestamp":1791849313435,"change":0.2975,"changeRate":0.026281,"amplitude":0.121095},"volumeRatio":0.22505812812767573},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RTSN\",,,,,undefined,":{"symbol":"RTSN","floatShares":3300000,"roa":"--","roe":"--","lyrEps":-10.687779,"volumeRatio":0.22505812812767573,"shares":8331600,"dividePrice":0,"high":11.79,"amplitude":0.154796,"preClose":10.53,"low":10.16,"week52Low":9.66,"pbRate":"-6.32","week52High":11.79,"institutionHeld":0,"latestPrice":11.32,"committee":-0.333333,"eps":-1.515,"divideRate":0,"volume":177617,"delay":0,"ttmEps":-1.515,"open":10.88,"prevYearClose":12,"prevWeekClose":10.53,"prevMonthClose":12,"prevQuarterClose":12,"fiveDayClose":12,"twentyDayClose":12,"sixtyDayClose":12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RTSN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RTSN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RTSN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RTSN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RTSN","date":"2026-10-12","current":-7.471947,"percent":1,"low":-7.018706,"twenty":-6.846748,"median":-6.588811,"eighty":-6.330873,"high":-6.158915,"avg":-6.588811,"sd":0.429895,"marketCap":87731737},"quantilePoints":[{"date":"2026-10-09","current":-7.018706,"twenty":-7.018706,"median":-7.018706,"eighty":-7.018706,"marketCap":99979188},{"date":"2026-10-12","current":-6.158915,"twenty":-6.846748,"median":-6.588811,"eighty":-6.330873,"marketCap":87731737}],"updateTime":1791890528066},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RTSN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674962865","title":"Retension Pharmaceuticals Shares Fall After Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2674962865","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674962865?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:37","pubTimestamp":1791563843,"startTime":"0","endTime":"0","summary":"Retension Pharmaceuticals  shares were down more than 11% in Friday trading after the company began trading on Nasdaq.The shares were trading at $10.64 after opening at $10 and reaching a high of $11.60.The company priced its initial public offering at $12 per share, expecting to raise $45 million in gross proceeds. The offering is expected to close Tuesday, Retension said late Thursday.Price: 10.64, Change: -1.37, Percent Change: -11.38","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LCLG","NQmain","RTSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144830990","title":"Retension Pharmaceuticals Debuts on US Stock Market, Shares Drop Over 10% After Opening","url":"https://stock-news.laohu8.com/highlight/detail?id=1144830990","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144830990?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:28","pubTimestamp":1791563294,"startTime":"0","endTime":"0","summary":"According to reports, on Friday, Retension Pharmaceuticals Inc (RTSN.US) listed on the US stock market. As of press time, the stock had fallen more than 10% to $10.77. The IPO price was $12.Retension...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","IBBQ","03069","BK1610","BBP","MRNX","RTSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674650865","title":"Retension Pharmaceuticals Shares Slide in Trading Debut After IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2674650865","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674650865?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:24","pubTimestamp":1791563040,"startTime":"0","endTime":"0","summary":"Retension Pharmaceuticals shares fell sharply in their trading debut after the clinical-stage biopharmaceutical company's upsized initial public offering was priced at the midpoint of expectations.Sha","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REDS","RTSN","KCE","FRHC","IPOS","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674856131","title":"City Therapeutics Eyes Valuation of up to $956.3 Million in US IPO Amid Biotech Listing Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2674856131","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674856131?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:13","pubTimestamp":1791544412,"startTime":"0","endTime":"0","summary":"City Therapeutics eyes valuation of up to $956.3 million in US IPO amid biotech listing pushOct 9 (Reuters)-City Therapeutics on Friday said it is targeting a valuation of up to $956.3 million in its ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL4N45V0R0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RTSN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RTSN\",params:#limit:6,delay:false,,,undefined,":[]}}